Sir, Fosfomycin [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid is a broad-spectrum antibiotic with bactericidal activity against both Gram-positive and Gram-negative bacteria. 1 Fosfomycin inhibits bacterial cell wall synthesis by inactivating the enzyme UDP-N-acetylglucosamine-3-enolpyruvyl transferase (MurA), which is essential for the catalysis of bacterial peptidoglycan biosynthesis. Thus, modification or overexpression of MurA can contribute to the development of fosfomycin resistance in bacteria. 2 Other common mechanisms of resistance to fosfomycin include decreased drug uptake and inactivation of the antibiotic by addition of various groups. 3 To date, several fosfomycin resistance genes have been functionally characterized in bacteria. FomA and FomB enzymes can inactivate fosfomycin by phosphorylation. 4 FosA, FosB and FosX can inactivate fosfomycin by catalysing the addition of glutathione, L-cysteine and H 2 O, respectively, to its epoxide ring. 2 Campylobacter species are the leading foodborne pathogens worldwide, accounting for 400 -500 million cases of diarrhoea each year. 5 Over the past few decades, Campylobacter species have become increasingly resistant to several clinically important antimicrobial agents, compromising the effectiveness of clinical therapy. 6 Various mechanisms of resistance to macrolides, fluoroquinolones, tetracyclines, aminoglycosides and b-lactams in Campylobacter have been extensively described. 7 In addition, clinical trials have indicated that fosfomycin can effectively treat Campylobacter enteritis in humans. 8 To date, no mechanism of fosfomycin resistance has been characterized in Campylobacter species. Here, we identified a novel fosX-like gene from Campylobacter coli (designated fosX CC ), located in the multidrug resistance genomic island (MDRGI), which confers fosfomycin resistance to Campylobacter species.
C. coli DZB4 was isolated from swine faeces in China in 2012. Our recent study indicated that DZB4 contains a type II MDRGI consisting of 10 ORFs that is inserted between cadF and CCO1582 on the chromosome (GenBank accession number KC876749) and this MDRGI can mediate antibiotic resistance, at least to macrolides, aminoglycosides and tetracycline. 9 Further analysis revealed that the fifth ORF, immediately upstream of erm(B), in type II MDRGI encodes a 136 amino acid protein that exhibits 26.9%, 34.2% and 63.9% identity to fosfomycin resistance determinants FosA, FosB and FosX found in Serratia marcescens (M85195), 10 Staphylococcus haemolyticus (X89875) 11 and Listeria monocytogenes (NP_465227.1), 2 respectively. Protein structure prediction indicated that this putative protein has identical quaternary structure to FosX and contains the conserved active site residue E44, which plays a key role in catalysis in FosX but not in FosA or FosB. 2, 12, 13 Considering that the fosfomycin MIC for isolate DZB4 was .512 mg/L, which is much higher than that for reference strains of Campylobacter such as Campylobacter jejuni NCTC 11168 and 81-176 (Table 1) , it is very likely that fosX CC confers fosfomycin resistance in Campylobacter.
To confirm that fosX CC was responsible for the fosfomycin resistance, fosX CC together with its promoter region was amplified from genomic DNA of isolate DZB4 by PCR [primers fosXbaI-F (5 ′ -AGCTCTAGAGCAAAATCTGGTTGTCATTG-3 ′ ) and fosXbaI-R (5 ′ -AGCTCTAGAGCACTCGTTAAAAAGTTTTGAG-3 ′ ); annealing temperature, 528C; amplicon size, 996 bp]. The amplicon was digested with XbaI and cloned into the pRRK plasmid, 14 which contains an aphA3 cassette in the opposite orientation to the ribosomal genes, to obtain plasmid construct pRRKfosX CC in Escherichia coli DH5a (Table 1 ). In the presence of glucose-6-phosphate, the E. coli construct DH5a+pRRKfosX
CC showed 512-fold increases in the MIC of fosfomycin compared with the WT DH5a strain (Table 1 ). In addition, pRRKfosX CC was then used as a suicide vector to insert fosX CC into the chromosome of fosfomycin-susceptible C. jejuni strain NCTC 11168 as well as two C. jejuni isolates of chicken origin, C1-89 and C114-1 (Table 1) , without fosfomycin resistance determinants. The transformants were selected on Mueller-Hinton agar containing kanamycin and were confirmed by PCR using primers fosXbaI-F and fosXbaI-R. The MICs of fosfomycin were increased by .16-fold for the C. jejuni construct 11168+aphA3+fosX CC compared with its WT parental strain. For the controls, the insertion of aphA3 into NCTC 11168 did not alter the susceptibility to fosfomycin. Similar to NCTC 11168, two C. jejuni chicken isolates, C1-89 and C114-1, showed .16-fold increases in the MICs of fosfomycin when they acquired the fosX CC gene (Table 1) . In this study, the presence of glucose-6-phosphate did not increase the bioactivity of fosfomycin in Campylobacter strains, which could be explained by the lack of the glucose-6-phosphate-inducible fosfomycin uptake transporter UhpT in Campylobacter species. 15 These results indicate that fosX CC is functional in both E. coli and Campylobacter and confers high-level resistance to fosfomycin. Our previous study showed that entire MDRGIs from Campylobacter species could be transferred between different strains. In this study, we successfully transferred fosX CC from donor strain C. coli DZB4 to the recipient strains C. jejuni NCTC 11168 and 81-176 using a natural transformation method. 9 fosX CC was detected in the transformants 11168DZB4 and 81-176DZB4 by PCR using primers fosXbaI-F and fosXbaI-R. 11168DZB4 and 81-176DZB4 exhibited .16-and 32-fold increases in the MIC of fosfomycin compared with NCTC 11168 and 81-176, respectively (Table 1 ). This result confirmed that the fosfomycin determinant and its associated MDRGI are transferable between Campylobacter strains.
In conclusion, this is the first report of the novel fosfomycin resistance gene fosX CC in Campylobacter. Although fosfomycin is seldom used in livestock, fosX CC was identified in this swine C. coli isolate. This gene is associated with a chromosomal MDRGI that harbours multiple antibiotic resistance determinants, including to macrolides, aminoglycosides and tetracycline, suggesting that selection pressure for other antibiotics used for clinical treatments or as feed additives could cause the selection and persistence of fosX CC in Campylobacter. In view of the fact that fosfomycin has a broad spectrum of antimicrobial activity, it could be a drug of choice to treat Campylobacter enteritis; however, the presence of fosX CC in Campylobacter would severely limit the use of fosfomycin in the clinical setting. Thus, enhanced efforts are needed to monitor the prevalence of this newly identified fosX CC gene and its associated MDRGI in Campylobacter spp. from farm animals and human diarrhoea cases. Absence of glucose-6-phosphate. c Numbers in parentheses indicate fold changes, increase from the susceptible strains ( ).
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Sir, In recent years, ESBL genes have been increasingly reported in Enterobacteriaceae from various animal species. In this regard, recent reports published in this journal have documented the emergence of CTX-M-15-producing strains in horses from different European countries, 1 -3 even the pandemic Escherichia coli sequence types ST131 and ST648. 2, 3 In this report, we describe the emergence of an MDR ST2179-CTX-M-15 E. coli strain co-producing RmtD and AAC(6 ′ )-Ib-cr in a foal with extraintestinal infection. In March, 2012, a 3-month-old English thoroughbred foal was admitted to a private equine clinic with signs of diarrhoea, mild dehydration, moderate colic, anorexia and prostration. The owner reported watery diarrhoea for 3 days, anorexia and weakness for over a week. Physical examination showed moderate to severe dehydration, pale mucous membranes, hyperthermia, rectal temperature of 418C, abdominal discomfort and distension, moderate colic, weakness and low body condition score. Treatment was initiated with intense fluids (lactated ringer solution), dexamethasone (0.2 mg/kg intravenously once a day) and 3 mg/kg gentamicin twice a day for 2 days. The clinical signs did not improve and the animal died 2 days after admission. Organ samples were aseptically collected and sent to the laboratory for microbiological investigation, where bacteriological cultures of liver yielded growth of a ceftiofur-resistant E. coli strain, named ICB-E10.
The identification of the isolate was confirmed by VITEK-2 (bioMé rieux, Marcy-l'É toile, France) and susceptibility and MICs were determined by Etest or agar dilution methods. 4, 5 The presence of ESBLs was screened by using Etest ESBL strips (bioMé rieux) and CHROMagar TM ESBL (France), and a range of
